[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334774-105":59,"doc-detail-334774-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","novel-role-of-llgl2-silencing-in-autophagy-reversing-epithelial-mesenchymal-transition-in-prostate-cancer","Novel role of LLGL2 silencing in autophagy - reversing epithelial-mesenchymal transition in prostate cancer","","Purpose: Prostate cancer is a major urological disease linked to morbidity and mortality, and LLGL2 is reported as a tumor suppressor in other cancers, yet its function and mechanism in prostate cancer remain unclear. This study examines how LLGL2 regulates epithelial-mesenchymal transition (EMT) through autophagy in vitro and in vivo. Methods: PC3 cells were transfected with siLLGL2 or LLGL2 plasmid, autophagy was assessed, and migration, invasion, and wound healing were measured; tumor growth used a shLLGL2 xenograft model. Results and conclusions: LLGL2 knockdown enhanced autophagy flux, inhibited EMT, and pharmacologic modulation showed that activating autophagy suppressed EMT while inhibition reversed the effects, suggesting LLGL2 as a therapeutic target via autophagy regulation.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/novel-role-of-llgl2-silencing-in-autophagy-reversing-epithelial-mesenchymal-transition-in-prostate-cancer/334774/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/novel-role-of-llgl2-silencing-in-autophagy-reversing-epithelial-mesenchymal-transition-in-prostate-cancer/334774.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-05","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main purpose of investigating LLGL2 in prostate cancer?","Question",{"text":112,"@type":113},"To determine how LLGL2 regulates epithelial-mesenchymal transition (EMT) through autophagy in prostate cancer, using both in vitro and in vivo approaches.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What experimental methods were used to study LLGL2 and autophagy?",{"text":117,"@type":113},"PC3 cells were transfected with siLLGL2 or an LLGL2 plasmid, autophagy was examined, and cell invasion, migration, and wound healing were assessed; tumor growth was evaluated using a shLLGL2 xenograft mouse model.",{"name":119,"@type":110,"acceptedAnswer":120},"How did LLGL2 knockdown affect EMT and autophagy markers?",{"text":121,"@type":113},"LLGL2 knockdown induced autophagy flux by upregulating Vps34 and ATG14L, and it inhibited EMT by increasing E-cadherin while decreasing fibronectin and α-SMA.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334774,1790141785,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Hong et al. Biological Research (2024) 57:25 Biological Research  \n[https://doi.org/10.1186/s40659-024-00499-w](https://doi.org/10.1186/s40659-024-00499-w)  \nRESEARCH ARTICLE Open Access  \nNovel role of LLGL2 silencing in autophagy: reversing epithelial-mesenchymal transition in prostate cancer  \nGeum-Lan Hong 1†, Kyung-Hyun Kim 1†, Yae-Ji Kim 1, Hui-Ju Lee 1, Sung-Pil Cho 1, Seung-Yun Han2, Seung Woo Yang4, Jong-Soo Lee 1, Shin-Kwang Kang3, Jae-Sung Lim4 and Ju-Young Jung 1*  \nAbstract  \nPurpose Prostate cancer (PCa) is a major urological disease that is associated with significant morbidity and mortality in men. LLGL2 is the mammalian homolog of Lgl. It acts as a tumor suppressor in breast and hepatic cancer. However, the role of LLGL2 and the underlying mechanisms in PCa have not yet been elucidated. Here, we investigate the role of LLGL2 in the regulation of epithelial-mesenchymal transition (EMT) in PCa through autophagy in vitro and in vivo. Methods PC3 cells were transfected with siLLGL2 or plasmid LLGL2 and autophagy was examined. Invasion, migration, and wound healing were assessed in PC3 cells under autophagy regulation. Tumor growth was evaluated using a shLLGL2 xenograft mouse model.  \nResults In patients with PCa, LLGL2 levels were higher with defective autophagy and increased EMT. Our results showed that the knockdown of LLGL2 induced autophagy flux by upregulating Vps34 and ATG14L. LLGL2 knockdown inhibits EMT by upregulating E-cadherin and downregulating fibronectin and α-SMA. The pharmacological activation of autophagy by rapamycin suppressed EMT, and these effects were reversed by 3-methyladenine treatment. Interestingly, in a shLLGL2 xenograft mouse model, tumor size and EMT were decreased, which were improved by autophagy induction and worsened by autophagy inhibition.  \nConclusion Defective expression of LLGL2 leads to attenuation of EMT due to the upregulation of autophagy flux in PCa. Our results suggest that LLGL2 is a novel target for alleviating PCa via the regulation of autophagy.  \nKeywords Autophagy, EMT, LLGL2, Proliferation, Prostate cancer  \n†Geum-Lan Hong and Kyung-Hyun Kim contributed equally to this work.  \n*Correspondence: Ju-Young Jung [jyjung@cnu.ac.kr](jyjung@cnu.ac.kr)  \n1Department of Veterinary Medicine, Institute of Veterinary Science, College of Veterinary Medicine, Chungnam National University, 99 Daehak-ro, Yusung-gu, Daejeon 34134, Republic of Korea  \n2Department of Anatomy, College of Medicine, Konyang University, Daejeon 35365, Republic of Korea  \n3Department of Thoracic and Cardiovascular Surgery, College of Medicine, Chungnam National University Hospital, Daejeon 35015, Republic of Korea  \n4Department of Urology, College of Medicine, Chungnam National University Hospital, Daejeon 35015, Republic of Korea  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nHong et al. Biological","cbCaissVh5rpguHu","https://ap.wps.com/l/cbCaissVh5rpguHu","pdf",11455304,11,"English","# Abstract\n# Introduction\n## Background on LLGL2 and prostate cancer\n## EMT and metastasis in cancer progression","[{\"question\":\"What was the main purpose of investigating LLGL2 in prostate cancer?\",\"answer\":\"To determine how LLGL2 regulates epithelial-mesenchymal transition (EMT) through autophagy in prostate cancer, using both in vitro and in vivo approaches.\"},{\"question\":\"What experimental methods were used to study LLGL2 and autophagy?\",\"answer\":\"PC3 cells were transfected with siLLGL2 or an LLGL2 plasmid, autophagy was examined, and cell invasion, migration, and wound healing were assessed; tumor growth was evaluated using a shLLGL2 xenograft mouse model.\"},{\"question\":\"How did LLGL2 knockdown affect EMT and autophagy markers?\",\"answer\":\"LLGL2 knockdown induced autophagy flux by upregulating Vps34 and ATG14L, and it inhibited EMT by increasing E-cadherin while decreasing fibronectin and α-SMA.\"}]","Novel role of LLGL2 silencing in autophagy - reversing epithelial-mesenchymal transition in prostate cancer | PDF",1790008335,28]